Evidence map›Paper›PMID 26056297›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Impaired mitochondrial fat oxidation induces adaptive remodeling of muscle metabolism.

Shawna E Wicks, Bolormaa Vandanmagsar, Kimberly R Haynie, Scott E Fuller, Jaycob D Warfel, Jacqueline M Stephens, Miao Wang, Xianlin Han, Jingying Zhang, Robert C Noland and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 1 synthesis or guideline pooled it, 130 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. TAK1 Regulates Skeletal Muscle Mass, Hypertrophic Signaling, and Metabolic Homeostasis in Male and Female Mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Skeletal muscle disorders as risk factors for type 2 diabetes.Molecular and cellular endocrinology · 2025
    Review
  14. Tissue specific roles of fatty acid oxidation.Advances in biological regulation · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Overexpression of CPT1A disrupts the maintenance and regenerative function of muscle stem cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Shawna E WicksGene Nutrient Interactions Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA 70808;
Bolormaa VandanmagsarGene Nutrient Interactions Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA 70808;
Kimberly R HaynieGene Nutrient Interactions Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA 70808;
Scott E FullerAdipocyte Biology Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA 70808;
Jaycob D WarfelGene Nutrient Interactions Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA 70808;
Jacqueline M StephensAdipocyte Biology Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA 70808;
Miao WangSanford-Burnham Medical Research Institute, Orlando, FL 32827;
Xianlin HanSanford-Burnham Medical Research Institute, Orlando, FL 32827;
Jingying ZhangTransgenic Core Facility, Pennington Biomedical Research Center, Baton Rouge, LA 70808;
Robert C NolandSkeletal Muscle Metabolism Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA 70808.
Randall L MynattGene Nutrient Interactions Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA 70808; Transgenic Core Facility, Pennington Biomedical Research Center, Baton Rouge, LA 70808; randall.mynatt@pbrc.edu.
Pennington Biomedical Research Center · USSanford Burnham Prebys Medical Discovery Institute · US

Funding

Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Leanne Maree Redman · 2005 to 2026
$26.5M
Mentoring Obesity and Diabetes Research in LouisianaP20GM103528 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI GETTYS, THOMAS W · 2012 to 2015
$8.8M
Training in Botanical Approaches to Combat Metabolic SyndromeT32AT004094 · NCCIH · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI BRANTLEY, PHILLIP J, STEPHENS, JACQUELINE M · 2009 to 2024
$5.7M
Training in Obesity ResearchT32DK064584 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI CORBY K MARTIN, Christopher D Morrison · 2003 to 2026
$5.3M
Defining the role of skeletal muscle peroxisomes in glucose homeostasisR01DK103860 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI NOLAND, ROBERT CHARLES · 2015 to 2019
$1.7M
Molecular Genetics of ThermogenesisR01DK089641 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI MYNATT, RANDALL LEE, YOUNG, MARTIN E · 2010 to 2013
$1.6M
Inhibition of CPT-1b in muscle: effects on glucose homeostasisR01DK098687 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI MYNATT, RANDALL LEE · 2013 to 2017
$1.6M
NCCIH NIH HHS T32 AT004094NIDDK NIH HHS 2P30-DK072476NIDDK NIH HHS P30 DK072476NIDDK NIH HHS R01 DK089641NIDDK NIH HHS R01DK089641NIDDK NIH HHS R01 DK098687NIDDK NIH HHS R01 DK103860NIDDK NIH HHS R01DK103860NIDDK NIH HHS T32 DK064584NIGMS NIH HHS 8P20-GM103528NIGMS NIH HHS 9P20-GM103528NIGMS NIH HHS P20 GM103528
6 · The paper itself

Abstract

The correlations between intramyocellular lipid (IMCL), decreased fatty acid oxidation (FAO), and insulin resistance have led to the hypothesis that impaired FAO causes accumulation of lipotoxic intermediates that inhibit muscle insulin signaling. Using a skeletal muscle-specific carnitine palmitoyltransferase-1 KO model, we show that prolonged and severe mitochondrial FAO inhibition results in increased carbohydrate utilization, along with reduced physical activity; increased circulating nonesterified fatty acids; and increased IMCLs, diacylglycerols, and ceramides. Perhaps more importantly, inhibition of mitochondrial FAO also initiates a local, adaptive response in muscle that invokes mitochondrial biogenesis, compensatory peroxisomal fat oxidation, and amino acid catabolism. Loss of its major fuel source (lipid) induces an energy deprivation response in muscle coordinated by signaling through AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) to maintain energy supply for locomotion and survival. At the whole-body level, these adaptations result in resistance to obesity.

Indexed as

Adaptation, PhysiologicalAnimalsCarnitine O-PalmitoyltransferaseFatty Acids, NonesterifiedMiceMice, KnockoutMitochondria, MuscleMuscle, SkeletalOxidation-ReductionCarnitine O-PalmitoyltransferaseFatty Acids, Nonesterifiedcarbohydratecarnitine palmitoyltransferasefatty acidlipidmuscle

Identifiers

PMID26056297
PMCPMC4485116
OpenAlexW1601325022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.